Discover and read the best of Twitter Threads about #alnov

Most recents (24)

(2011) #Roche launched the LightCycler Nano POC 🔬

Via white label with IT-IS who also licensed to @NovacytGroup (sold as q32 + q16)

2014 IT-IS sought legal damages against Roche for patent infringement

2020 @NovacytGroup bought IT-IS
#Novacyt #ALNOV
"Many research labs use 96-well instruments, but the average number of samples per run is often below the capacity of the instruments"

🤏 "should satisfy the needs of many PCR researchers by fitting well into their work environment"
Roche Marketing VP Fernandes-McAlear

“The new LightCycler® Nano Instrument delivers proven high quality at an affordable price & expands our qPCR business into a new segment. Customers will love the smart design of the instrument & appreciate the high quality data they can produce with it.”

Gerd Haberhausen, Roche
Read 7 tweets
Fact check:
#Novacyt Exsig underwent Clinical & NHS validation

👇 Wrong:
"So in essence if you look you will not find a document (that I have ever seen) saying Exsig formally passed its in service trial in relation to the contract whereas you will find one for Promate"

For supposed researched person, he's lazy. His thesis called out #Novacyt's 3rd party manufacturing for lowering margins

#ALNOV "invests in infrastructure to bring previously outsourced work in-house & to drive further automation, leading to improved margins & process controls"
Read 6 tweets
#ncyt #alnov #novacyt

That's nice. PROmate, as part of the national microbiology framework has it's own contract.

The £4m amount until next Year has been announced by @NovacytGroup a few weeks ago. But without any minimal amount secured as stated.

#ncyt #alnov #novacyt

Now we have the contract in front of us.

"By execution of the contract, DHSC shall submit to the supplier a purchase order for the sum of xxxxx"

Interesting 🧐

#ncyt #alnov #novacyt

Our relation with DHSC is far from over.
Monthly meetings to review several points.

Thanks to Steve Gibson, CFO, for signing this contract on behlaf of @NovacytGroup 🧐

Read 4 tweets
2020 Figure's:

🇬🇧 70% sales NHS/DHSC
👨‍💼 18% via Distributors (UK & International)
🔬 12% Private Lab sales

#Novacyt #ALNOV #NCYT
10 COVID products launched

ProMATE simplifies sample preparation, to be applied to:

Infectious diseases

"targeted niches where we believe there is still very high unmet medical need"

"faster, more accurate or easier diagnosis" #Novacyt #ALNOV #NCYT

"Management's confidence in settling the outstanding commercial dispute"

If dispute isn't favourably resolved #Novacyt has sufficient cash untill June 2022 without need to raise finding

Read 14 tweets
#Novacyt's COVID-19 tests received UKAS Medical Accreditation for use within 4 UK private labs in past month

✅ The Scientists Laboratory Ltd (10k daily capacity)
✅ Epistem Ltd
✅ MDNA Life Sciences Ltd

Courtesy of @BlackbirdInvest

Wren Healthcare received UKAS Accreditation for use of #Novacyt's Point of Care solution

Q16/32's with ProMATE, no bio hazard safety cabinet required

At least 9 Versalabs have been supplied with approx 900 daily capacity each #ALNOV #NCYT

Thank you @Larry64450205
Read 4 tweets
While we await Q&A answers from & AGM agenda next week from @NovacytGroup here are some of the slides & video

Diagnostics set to boom 💥

#novacyt #ALNOV #NCYT building blocks in place for sustained growth

#Novacyt #ALNOV #NCYT

Busy with clinical trials 👩🏼‍🔬
#Novacyt #ALNOV #NCYT

Catalogue of assays ready to convert to ProMATE & q16/32 🔬 platform

Company readying to turn into a Point of Care diagnostics leader
Read 11 tweets
#ncyt #alnov #novacyt

A little mixed thread.

Our R&D, the bioinformatic reports, SNPsig, PROmate, Versalab, DHSC, takeovers, the RNSs, wierd stuff, whats next, some risks, etc

Waiting for AF LFT.
1m tests/week to start.
Shouldnt be long to wait, as theyre already looking for tenders for it. (See UN notice of interest)

For home use and professionnals. Very important. It opens many markets !

Read 20 tweets
Novacyt has over 550+ tests.

So why haven't they been doing billions in revenue like their peers, and why are we expecting them to go mid cap like other diagnostics companies, now.

What's changed and why have investors been backing sustainable mid cap revenues?

When Novacyt acquired PrimerDesign in 2016, it was for their portfolio of tests and the talent within that team.

However those tests were research use only (RUO), and PrimerDesign themselves were not structured as a business that could sell into the clinical use market.
You have seen how much PCR tests cost. But you have also seen the accuracy needed and competition in that market. That competition exists for good reason - it's worth billions and has a 17.5% CAGR from 2020 to 2027.
Read 24 tweets
Extremely bullish by SourceBio this morning.

Novacyt is always extremely conservative with market communications, though they're at two different stages. Novacyt is making mid cap money, but talking like an uncertain micro cap in RNS. Hence the chaos.


If you look at non-market facing communications from @NovacytGroup at the moment. They're extremely bullish and confident about who they are and what they're doing.

Led the way on swine flu, covid and the horse meat scandal. Strong USPs. Image
Sales director role with heady focus on NHS sales. Many roles are NHS facing. So many people are confused over the procurement dispute. That's just one contract, and just one part within that contract. Not a breakdown in a relationship. Image
Read 14 tweets
Bad spells are a show of character. You learn about people from it, on all sides of the equation.

Same with the brokers' reactions

SP Angel actually did the decent thing and held back from putting out a target until Mullis has had a bit more time to update them 👍

Numis taking a moderate view, which although ridiculous around £5.70 for a company like this - they are starved of info on the next product and revenue streams, so can't fault them too strongly until sustained revenues are made official.
ODDO though.

Almost a parody of a dodgy brokerage, complete opportunists. They will have a clue a news flow period is coming up soon. Mullis has made that much clear - new tech and contracts in process for covid, and a longer sustained business plan.
Read 12 tweets
Not a huge horse racing fan, but Rachel's amazing.

Her jersey, not so much.

Makes you realise though...

That all the main players have an advertising budget. I notice it because of the website. But Roche, Thermo, Qiagen etc are always there in my face. Constant ad spend, even on low volume blogs..
Smaller players, SourceBio etc.. all advertising.
Read 24 tweets
So that's it. We can all move on now from the DHSC albatross around Novacyt's neck.

People selling off, shorts and MMs sticking the knife in.

But after that settles, we've actually got some good material in this RNS.

We have multiple COVID-19 LFTs coming.

Now confirmed by RNS so we will have a complete revenue stream for COVID-19 that only large caps like Roche have managed to output.

We actually will have a wider range than some large caps ie. Thermo & Perkin Elmer.

Very impressive.
We've done £30 to £40mill in Q1 2021 from private testing sales and have yet to launch several new products, including LFTs which are currently en-vogue.

Novacyt's team is expanding and pushing into new territories so 2021 revenues without DHSC are still mid cap level.
Read 16 tweets
#Novacyt more than COVID-19 🔬

🔎 550 non COVID range

. Human pathogen
. Veterinary
. Food, water & agriculture
. Bio threats
. Genotyping

Find out in April how #NCYT will leveraging it's role within 🇬🇧 diagnostics infrastructure

#ALNOV #Primerdesign
#Novacyt's Genesig tests are designed to run on the q16 & larger q32 which is one of the fastest qPCR instruments in the world

I'm looking forward to seeing ProMATE being adapted to further simplify #NCYT testing base
#Novacyt have a Massive range of Respiratory Infection detection kits

& as demonstrated by COVID they are fast to react to new threats

& now UK has the tools & political will to test

#Novacyt #ALNOV #NCYT #Primerdesign
Read 14 tweets
Major flex by Novacyt today in response to ridiculous market conditions.

Decentralised testing flex.
Centralised testing flex.
LFT flex.
Validations flex.

Non-covid roadmap in Q2 will get the hype train moving shortly too.

As always with a Novacyt infodump it takes weeks for the gravity of it to settle. All this tech will be realised in 2021+ in terms of revenues and growth. But it's all in there.

Initial thoughts?
LFT modification to 'extend the revenue horizon for COVID-19'.

Many antibody LFTs on market simply haven't been selling. Uptake isn't there, especially in the UK. The requirements for these have changed, and the major rollout won't be until we have greater vax numbers.
Read 20 tweets
sent another reminder to Eurobio-Scientific (#ALERS) about my questions about the PCR test.

I received an answer this time:

"It is company policy not to communicate with specific investors in order to maintain equal access to information."


"I cannot answer your quite detailed questions."

Uhm, I'm only asking about the products, not about sensitive financial information.

Why not disclose this information?

I received the official Package Insert fur Flucosyn though.

Eurobio-Scientific is the biggest supplier of France and also a big exporter of PCR tests.

What did I find?

Read 11 tweets
BCG analyzed 🔬 🇺🇸, 🇫🇷 , 🇩🇪 , 🇮🇹, 🇪🇸 Outlook

Testing's likely to follow similar trajectories

Peak COVID demand occurring in the seasonally affected first quarters of 2021 & 2022

#Novacyt #ALNOV #NCYT…
BCG anticipate continued need for testing in 2023 & 2024

Even if vaccines prove to be highly effective, the need to test people for COVID-19 will continue, for at least five reasons

#Novacyt #ALNOV #NCYT

. Epidemiology of the COVID-19 🧬
. Impact of the vaccines 💉
. Impact of therapeutics 💊
. Government policy 📜

What makes a good test 🔍
#Novacyt #ALNOV #NCYT
Read 5 tweets
Don't you wonder sometimes
About genes and vision?

#Novacyt #ALNOV #NCYT

“Our SNPsig assays are the same high level of accuracy as our PCR SARS-CoV-2 portfolio,” Mullis said. More variants will be added as they are identified.

“primary challenge for COVID-19 diagnostics companies is ensuring their products continue to accurately test for the virus, regardless of the variant, and to innovate at the challenging pace required to remain clinically relevant"

Graham Mullis #Novacyt…

#NCYT launched PCR genotyping assay portfolio to detect COVID-19 variants

#ALNOV The SNPsig portfolio is designed to run on central laboratory systems & on the company’s q16 and q32 rapid PCR systems
Read 7 tweets
Prof Sharon Peacock Cambridge Uni, her work sequencing variants may be required for at least 10 yrs…

#Novacyt #ALNOV #NCYT
(April) Novacyt Partners With AstraZeneca, GSK, University Of Cambridge To Increase COVID-19 Testing

#Novacyt #ALNOV #NCYT
Read 13 tweets
UK micro > small cap 🔬 snap shot

Sales - £277m
Cash - £92m
COVID prods on sale - 10+
Market Cap - £565m

#Abingdon, #BBI, #Omega, #Avacta, #GeneDrive (#GDR) & #Yourgene

Sales - £28m > £30m (Yourgene £18>£20m)
Cash - 🤔
COVID prods on sale - 3🤔
Market Cap - £761m Image
There's a margin of error to account for BBI accounts which aren't public, awaiting GeneDrive which reports 31/03, Avacta account were published 23/01 last yr.

Say £5m tops. Small fry when you consider imbalance of collective market capitalisations.
AIM 2020 Top % Risers (cash / Mcap)
#NCYT - £91.8m / £553m
#AAA - £10.2m / £204m
#SNG - £10.9m / £305m
#GGP - £6m / £983m
#EQT - €1.7m / £156m
#SVE - £118k / £13m
#EUA - £50.8k / £759m
#MNO - £1.43m / £25m
#PHE - £5m / £306m
#OMI - £7.6m / £51m

*info as per latest relevant RNS Image
Read 10 tweets
#ncyt #alnov #novacyt

SP Angel published a New note on #ncyt

You Can Access the full document here :…

The target Price is 1433p, but there are many interesting things in this document.

Thread ⤵️
1/15 Image
First, the FY2020 results are better than in the last forecast.

Actual vs previous forecast
Revenue 311m vs 287m
Cash 101m vs 79m

The cash accumulated will allow them to develop themselves into a "high margin clinical diagnostics" sector.

2/n Image
Revenues and forecast.

Things are really important here.
We Can see the revenues decrease until 2023 on this forecast.

But look at the cash accumulation. This will not sit in the bank and wait !

So, when they use this cash for aquisitions for ex.,

3/n Image
Read 15 tweets

Coming clean.

There's a deceit that goes around the social media game when it comes to pushing stocks and many of us are admittedly a part of that.

The 1st deceit is the lack of emphasis on how extremely volatile the market is for any particular stock on AIM - it only really gets discussed after the fact, like today for example.

30% and 40% swings in a week is extreme.
You're better off trading that.

We all know it.
Read 27 tweets
#ncyt #alnov

#novacyt has a great capacity in identifying the needs of the market.

Many tests developped this year respond to precise needs

And there are many more to Come this year

- History
- promate & its future
- rt-lamp
- sequencing and variants

Thread 1/17 ⤵️
Little History.

- covid-HT was specificly developped for the AZN lighthouse lab in Cambridge

- Winterplex was one of the first of his kind, developped to answer the needs of NHS

- exsig direct direct to symplify the workflow of the PCR

- mink strain test : theyre the first ones, again, for this test, who could have had a sognificant importance if this strain had spread

Read 17 tweets
#Zwift Meetup 4pm today 🚴🚴‍♂️

We're testing a group meet where you can do any workout or training plan you like, yet the group stays together using the new Meet Up Keep Together function!


This hack:…
If you fancy doing 3 or 4 workouts a week, load up a plan that suits you and stay motivated by joining the Meet Ups at 5:30pm Tuesday and Thursday then earlier rides Sat & Sunday. Times could change this week to group's preference though.
If you fancy testing doing a workout while in a group meetup then pop along today, post here and get invited in game!

Level or experience doesn't matter ☺️

Reply here if interested!
Read 5 tweets
📹 is worth a thousand 🖋

ProMATE saving many pipettes steps 🧫

Better 🥳 (work flow)

Faster 🏃 (180 mins to 80)

Safer ☣ (no need for Class ii cabinet)

#Novacyt #ALNOV #NCYT

Taking it to the next phase

It's simple, @PrimerdesignLtd designed it that way

Efficient workflow, further enabling Point of Care testing within NHS settings 👨‍🔬 & beyond 👩🏻‍🔬🗺️ Image
The Q16, Q32 ProMATE squad 🧬🔬👨‍🔬🏆

#Novacyt #ALNOV #NCYT Image
Read 10 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!